Professional Documents
Culture Documents
338 | www.annalsplasticsurgery.com Annals of Plastic Surgery • Volume 64, Number 3, March 2010
Annals of Plastic Surgery • Volume 64, Number 3, March 2010 Effects of Single Application of Extractum Cepae
Number of Specimen
Second and third toes were used for histopathologic evalua-
tions. The tendon/sheath complexes went through a standard proce- 4
dure of fixation using 10% neutral formalin and decalcification
solution for a period of 48 hours, which allowed the excision of the
specimens. The tendons were cut longitudinally and embedded in 2
Treatment group
paraffin after routine processing. Serial sections were prepared and
stained with hematoxylin and eosin. 0 Control group
The grading scale of Tang et al19 was used to evaluate the extent None Minimal Medium Severe
and severity of the formation of adhesions in the peritendinous region
(Table 1). In this grading system the adhesions were evaluated both Adhesion grades
quantitatively and qualitatively. The extents of the adhesions were
FIGURE 1. Schematic presentation of the adhesion grades in
classified into 4 grades: no adhesions, slight (minimal) adhesions,
the control and treated tendons.
moderate (medium) adhesions, and severe adhesions.
An experienced histopathologist performed the review as a
blind observer without having any information about the tendons.
TABLE 2. Histopathologic Evaluation Results of the Control
Biomechanical Tests and Extractum Cepae-Treated Group
The first toes were selected to test the ultimate load of the Adhesion Grades
injured tendon. Tendons were vertically held in the nonslipping jaws
of soft tissue clamps, which were mounted onto a material testing Non Minimum Medium Severe
machine (model TIRA test 24500; Demgen, Werkzeugbau, GmbH, N n (%) n (%) n (%) n (%)
Schwerte, Germany). All specimens were subsequently loaded to Group 1 (treatment) 18 1 (5.6) 8 (44.4) 6 (33.3) 3 (16.7)
failure point at a static rate of 20 mm/min and force versus displace- Group 2 (control) 18 1 (5.5) 1 (5.5) 3 (16.6) 13 (72.4)
ment data was recorded.
Biomechanical data were analyzed using the Mann-Whit-
ney-U test. The 2 test was used to analyze the histologic results. A
significant difference was found in ultimate load between the 2
P value of less than 0.05 was considered statistically significant.
group (P ⫽ 0.323).
Biomechanical Results Histopathologic Findings
Ultimate load of the tendons was (47.11 ⫾ 1.33 N) for the
Adhesion formation was absent in 1 tendons (5.5%), slight in
treatment group and (46.16 ⫾ 1.54 N) for the control group. No
8 (44.4%), moderate in 6 (33.3), and severe in 3 tendons (16.7%) in
group I (treated tendons); while in group II (untreated tendons), it
was absent in 1 tendon (5.5%), slight in 1 tendons (5.5%), moderate
TABLE 1. Criteria Described by Tang et al19; A Histologic in 3 (16.6%), and severe in 13 (72.4%) (Fig. 1, Table 2).
Evaluation of Adhesions There was significantly less adhesions (severe and medium
grade) in the treatment group compared with control group (P ⫽ 0.01).
Points Features of Adhesion
Quantity DISCUSSION
0 No apparent adhesions Various pharmacologic agents have been experimented to
1 A number of scattered filaments minimize the restrictive adhesion and improve the functional out-
2 A large number of filaments come after flexor tendon injuries. The reduction in synovial reaction
3 Countless filaments and adhesion formation using “one touch” technique has been
Quality
proved in previous experimental studies.2,6,7
In our study, we tested the hypothesis that the use of extrac-
0 No apparent adhesions
tum cepae will be safe and reduce the extent of peritendinous
1 Regular, elongated, fine, filamentous adhesion formation after tendon injuries. For this purpose, a rabbit
2 Irregular, mixed, shortened, filamentous flexor tendon injury model was used.
3 Dense, not filamentous Histopathologically, extractum cepae treated group showed
Grading of adhesions significantly less adhesion (Fig. 2) compared with the control group
0 None (Fig. 3). In the treatment group, less fibrosis and less adhesion
1–2 Slight (minimal) formation revealed that less reaction and adhesion occurred around
3–4 Moderate (medium) the tendon in this group. The tendon, incision site, and the skin
5–6 Severe healed completely in both groups and no infection was observed in
either group.
5. Ozgenel GY. The effects of a combination of hyaluronic and amniotic in prevention of scarring in Chinese patients having laser removal of tattoos:
membrane on the formation of peritendinous adhesions after flexor tendon a prospective randomized controlled trial. Dermatol Surg. 2006;32:891– 896.
surgery in chickens. J Bone Joint Surg Br. 2004;86:301–307. 16. Maragakis M, Willital GH, Michel G, et al. Possibilities of scar treatment
6. Akali A, Khan U, Khaw P, et al. Decrease in adhesion formation by a single after thoracic surgery. Drugs Exp Clin Res. 1995;21:199 –206.
application of 5-fluorouracil after flexor tendon injury. Plast Reconstr Surg. 17. Willital GH, Heine H. Efficacy of Contractubex gel in the treatment of fresh
1999;103:151–158. scars after thoracic surgery in children and adolescents. Int J Clin Pharmacol
7. Khan U, Sakar S, Akali A, et al. Modulation of the formation of adhesions during Res. 1994;14:193–202.
the healing of injured tendons. J Bone Joint Surg Br. 2000;82:1054–1058. 18. Saulis A, Mogford J, Mustoe T. Effect of Mederma on hypertrophic scarring
8. Namba J, Shimada K, Saito M, et al. Modulation of peritendinous adhesion in the rabbit ear model. Plast Reconstr Surg. 2002;110:177–183.
formation by alginate solution in a rabbit flexor tendon model. J Biomed 19. Tang JB, Shi D, Zhag QG. Biochemical and histologic evaluation of tendon
Mater Res B Appl Biomater. 2007;80:273–279. sheath management. J Hand Surg Am. 1996;21:900 –908.
9. Bates SJ, Morrow E, Zhang AY, et al. Mannose-6-phosphate, an inhibitor of 20. Sengupta A, Ghosh S, Bhattacharjee S. Allium vegetables in cancer preven-
transforming growth factor-beta, improves range of motion after flexor tion: an overview. Asian Pacific J Cancer Prev. 2004;5:237–245.
tendon repair. J Bone Joint Surg Am. 2006;88:2465–2472. 21. Choi JA, Kim JY, Lee JY, et al. Induction of cell cycle arrest and apoptosis
10. Johri RK, Zutshi U, Kameshwaran L, et al. Effect of quercetin and Albizzia in human breast cancer cells by quercetin. Int J Oncology. 2001;19:837– 844.
saponins on rat mast cells. Indian J Physiol Pharmaco. 1985;29:43. 22. Brady JF, Ishizaki H, Fukuto JM, et al. Inhibition of cytochrome P450 IIE1
11. Castillo MH, Perkins E, Campbell JH, et al. The effects of the bioflavonoid by diallyl sulfide and its metabolites. Chem Res Toxicol. 1991;4:642– 647.
quercetin on squamous cell carcinoma of head and neck origin. Am J Surg. 23. Avila MA, Velasco JA, Cansado J, et al. Quercetin mediates the down-
1989;158:351–355. regulation of mutant p53 in the human breast cancer cell line MDA-MB468.
12. Pawlikowska-Pawlega B, Gawron A. Effect of quercetin on the growth of Cancer Res. 1994;54:2424 –2428.
mouse fibroblast cells in vitro. Pol J Pharmacol. 1995;47:531–535. 24. Avila MA, Velasco JA, Harter KW, et al. Quercetin as a modulator of the
13. Molnar J, Beladi I, Domonkos K, et al. Antitumor activity of flavonoids on cellular neoplastic phenotype. Adv Expl Biol. 1996;401:101–110.
NK/Ly ascites tumor cells. Neoplasma. 1981;28:11–18. 25. Yoshida M, Yamamoto M, Nikaido T. Quercetin arrests human leukemic
14. Payasli C, Hosnuter M, Tekerekoglu B, et al. The effects of onion extract on T-cells in late G1 phase of the cell cycle. Cancer Res. 1992;52:6676 – 6681.
hypertrophic and keloid scars. J Wound Care. 2007;16:251–254. 26. Boyle SP, Dobson VL, Duthie SJ, et al. Absorption and DNA protective effects
15. Ho WS, Ying SY, Chan PC, et al. Use of onion extract, heparin, allantoin gel of flavonoid glycosides from an onion meal. Eur J Nutr. 2000;39:213–223.